Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells.


We evaluated the expansion capacity of untreated and 5-fluorouracil (5-FU)-resistant peripheral blood stem cells (PBSC) after 7-day incubation with interleukin-1 (IL-1) plus IL-3 plus stem cell factor (SCF) or with medium alone. We found a significant increase in the proportion of CD34+ cells in the PBSC fraction resistant to 25 micrograms/mL 5-FU after 7-day incubation with IL-1 plus IL-3 plus SCF as compared with the untreated fraction (p = 0.011). We also showed that 5-FU-resistant PBSC have a greater capacity for expansion of IL-1/IL-3/SCF-responsive immature progenitors (p = 0.05), amplification of IL-3 plus GM-CSF responsive progenitors (p = 0.01), and production of committed single growth factor-responsive (granulocyte-macrophage colony-stimulating factor [GM-CSF]) precursors (p = 0.01) than the untreated PBSC. The expansion of all types of progenitors and CD34+ cells was only observed after 7-day incubation with IL-1 plus IL-3 plus SCF. These results suggest that PBSC contain a primitive stem cell population with an enhanced expansion capacity that is identified by 5-FU resistance. As these cells can be expanded in vitro, they may then be suitable for a number of clinical applications.


Citations per Year

106 Citations

Semantic Scholar estimates that this publication has 106 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Rice1995CytokinemediatedEO, title={Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells.}, author={Adrian Rice and J. M. Boiron and C{\'e}line Barbot and Maryse Dupouy and Nadine Dubosc-Marchenay and Patrice Dumain and Francis Lacombe and Jose J. Reiffers}, journal={Experimental hematology}, year={1995}, volume={23 4}, pages={303-8} }